blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3508856

EP3508856 - NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  30.12.2022
Database last updated on 02.09.2024
FormerRequest for examination was made
Status updated on  07.06.2019
FormerThe international publication has been made
Status updated on  10.03.2018
Most recent event   Tooltip27.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Lu, Fengmin
Peking University Health Science Center
38 Xueyuan Road
Beijing 100191 / CN
For all designated states
Yao, Mingjie
Peking University Health Science Center
38 Xueyuan Road
Beijing 100191 / CN
For all designated states
Zhao, Jingmin
Beijing 302 Hospital
100 Xisihuan Road
Beijing 100039 / CN
[2019/28]
Inventor(s)01 / LU, Fengmin
Peking University Health Science Center
38 Xueyuan Road
Beijing 100191 / CN
02 / YAO, Mingjie
Peking University Health Science Center
38 Xueyuan Road
Beijing 100191 / CN
03 / ZHAO, Jingmin
Beijing 302 Hospital
100 Xisihuan Road
Beijing 100039 / CN
 [2019/28]
Representative(s)Ipsilon
Le Centralis
63, avenue du Général Leclerc
92340 Bourg-la-Reine / FR
[N/P]
Former [2019/28]Peguet, Wilfried, et al
Ipsilon
Le Centralis
63, avenue du Général Leclerc
92340 Bourg-la-Reine / FR
Application number, filing date17845449.230.08.2017
[2019/28]
WO2017CN99714
Priority number, dateCN20161079829131.08.2016         Original published format: CN201610798291
[2019/28]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018041147
Date:08.03.2018
Language:ZH
[2018/10]
Type: A1 Application with search report 
No.:EP3508856
Date:10.07.2019
Language:EN
[2019/28]
Search report(s)International search report - published on:CN08.03.2018
(Supplementary) European search report - dispatched on:EP19.03.2020
ClassificationIPC:G01N33/68, G01N33/576
[2020/17]
CPC:
G01N33/576 (EP); G01N33/6893 (CN,US); G01N33/5767 (EP);
G01N33/68 (US); G01N2800/085 (EP,CN,US); G01N33/57438 (US)
Former IPC [2019/28]G01N33/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/28]
TitleGerman:NEUARTIGER LEBERZIRRHOSE- ODER LEBERFIBROSEMARKER[2019/28]
English:NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER[2019/28]
French:NOUVEAU MARQUEUR DE LA CIRRHOSE DU FOIE OU DE LA FIBROSE DU FOIE[2019/28]
Entry into regional phase29.03.2019Translation filed 
29.03.2019National basic fee paid 
29.03.2019Search fee paid 
29.03.2019Designation fee(s) paid 
29.03.2019Examination fee paid 
Examination procedure27.06.2018Request for preliminary examination filed
International Preliminary Examining Authority: CN
29.03.2019Examination requested  [2019/28]
14.10.2020Amendment by applicant (claims and/or description)
04.01.2023Despatch of a communication from the examining division (Time limit: M06)
08.06.2023Reply to a communication from the examining division
Fees paidRenewal fee
26.08.2019Renewal fee patent year 03
28.08.2020Renewal fee patent year 04
30.08.2021Renewal fee patent year 05
30.08.2022Renewal fee patent year 06
25.08.2023Renewal fee patent year 07
27.08.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2005026687  (UNIV JEFFERSON [US], et al) [X] 9-11 * whole document, in particular claims 1-22 *;
 [A]WO2008060394  (INOVA DIAGNOSTICS INC [US], et al) [A] 1-11* the whole document *;
 [X]CN101328214  (GUANGZHOU INST BIOMED & HEALTH [CN]) [X] 9-11 * whole document, in particular claims 1-7 *;
 [X]CN101735319  (BEIJING HOTGEN BIOTECH CO LTD) [X] 9-11 * whole document, in particular claims 1-10 *;
 [X]CN103604918  (GUANGZHOU INST BIOMED & HEALTH, et al) [X] 9-11 * whole document, in particular claims 1-10 *;
 [X]US2014134606  (NEWMAN GALE W [US], et al) [X] 9-11 * whole document, in particular claims 1-20 *;
 [XA]CN105189549  (ABBOTT LAB) [X] 9-11 * whole document, in particular par. 26, 29, 101, 111, 182, 241, 269, 272, 297, 310, 329-340 * [A] 1-8;
 [X]  - QIAO YONG ET AL, "Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection", CLINICAL BIOCHEMISTRY, ELSEVIER INC, US, CA, (20140825), vol. 47, no. 16, doi:10.1016/J.CLINBIOCHEM.2014.08.010, ISSN 0009-9120, pages 216 - 222, XP029091575 [X] 9-11 * whole document, in particular abstract *

DOI:   http://dx.doi.org/10.1016/j.clinbiochem.2014.08.010
 [X]  - TAN Q EN,GUO WEI,ZHANG CHUNYAN, JIONG ET AL, "Value of Golgi protein 73(GP73) for diagnosis and grading of liver cirrhosis", ZHENDUANXUE LILUN YU SHIJIAN -JOURNAL OF DIAGNOSTICS CONCEPTS & PRACTICE, SHANGHAI RUIJIN YIYUAN, CN, (20131231), vol. 12, no. 5, ISSN 1671-2870, pages 516 - 521, XP009513624 [X] 9-11 * whole document, in particular abstract *
International search[X]WO2005026687  (UNIV JEFFERSON [US], et al) [X] 1-13 * , claims 1-22 *;
 [X]CN101328214  (GUANGZHOU INST BIOMED & HEALTH [CN]) [X] 1-13 * , claims 1-7 *;
 [X]CN101735319  (BEIJING HOTGEN BIOTECH CO LTD) [X] 1-13 * , claims 1-10 *;
 [X]CN103604918  (GUANGZHOU INST BIOMED & HEALTH, et al) [X] 1-13 * , claims 1-10 *;
 [X]US2014134606  (NEWMAN GALE W [US], et al) [X] 1-13 * , claims 1-20 *;
 [X]CN105189549  (ABBOTT LAB) [X] 1-13 * , description, paragraphs [0026], [0029], [0101], [0111], [0182], [0241], [0269], [0272], [0297], [0310] and [0329]-[0340] *;
 [PX]CN106405104  (LU FENGMIN, et al) [PX] 1-13 * , claimsl-13 *;
 [PX]  - LU , FENGMIN, "Serological diagnosis of hepatocellular carcinoma: challenges and opportunities", Journal of Clinical Hepatology, (20170731), vol. 33, no. 7, doi:10.3969/j.issn.1001-5256.2017.07.011, ISSN 1001-5256, pages 1262 - 1265, XP009513598 [PX] 1-13

DOI:   http://dx.doi.org/10.3969/j.issn.1001-5256.2017.07.011
 [X]  - QIAO, Y. et al., "Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection", Clinical Biochemistry, (20140825), vol. 47, doi:doi:10.1016/j.clinbiochem.2014.08.010, pages 216 - 222, XP029091575 [X] 1-13

DOI:   http://dx.doi.org/10.1016/j.clinbiochem.2014.08.010
 [X]  - TAN, QIWEN et al., "Value of Golgi protein 73(GP73) for diagnosis and grading of liver cirrhosis", Journal of Diagnostics Concepts & Practice, (20131231), vol. 12, no. 5, ISSN 1671-2870, pages 516 - 521, XP009513624 [X] 1-13
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.